A study of prescription pattern in the drug therapy of chronic kidney disease


Kiran A Kantanavar, Rajendra Holla, Shobhana Nayak Rao




Objectives: a) To analyze the pattern of drug prescription for chronic kidney disease and its co-morbid conditions, if exist. b) To study the rationality of drug therapy.

Methodology: Over a period of 1 year, the discharge-summary records of 188 patients with CKD, admitted to nephrology wards of Justice K. S. Hegde Charitable Hospital, Mangaluru, were scrutinized and the data collected in a specially designed proforma. Descriptive analysis of the data was done.

Results: Of the total 188 patients, 101(53.7%) were males and 87 (46.3%) females. Highest numbers of patients were in the age group of 58-67 years (29.3%). Hypertension was the most common co-morbidity (82%) observed, followed by anaemia (54.8%) and type 2 diabetes (43%). A total of 1436 drugs were prescribed to 188 CKD patients. Each patient received an average of 7.6 drugs. Polypharmacy was seen in all patients. Drugs acting on the cardiovascular system constituted the bulk of the prescriptions (31%) followed by nutritional Supplements (15.3%), haematinics (10.7%) and the drugs acting on gastrointestinal system (10.3%). Other important categories of drugs prescribed included antimicrobials (5.8%), antiplatelets and hypolipidaemic agents (5%), antidiabetic drugs (4.7%) and phosphate binders (4%).

Conclusion: This study shows that the management of chronic kidney disease in the nephrology department of Justice K. S. Hegde Charitable Hospital, is in congruity with the rational utilization of medicines which is based on the clinical knowledge, expertise and the guidelines accessible in the field of nephrology practice.




Rational prescription; chronic kidney disease; nephrology


Full Text:




Hill NR, Fatoba ST, Oke JL, Hirst JA, OCallaghan CA, Lasserson DS, et al. Global Prevalence of Chronic Kidney Disease A Systematic Review and Meta-Analysis. PLoS ONE 2016; 11 (7): e0158765. doi:10.1371/journal.pone.0158765.

Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC study. Kidney Int 2003; 64:610615.

Kausz AT, Khan SS, Abichandani R, et al. Management of patients with chronic renal insufficiency in the northeastern United

States. J Am Soc Nephrol 2001; 12:15011507.

Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cross-sectional study. BMC Health Serv Res. 2013; (13): 170.

WHO, Rational use of medicines. Available from: http://www.who.int/medicines/areas/rational_use/en/

Shankar PR, Upadhyay DK, Subish P, Dubey AK, Mishra P.

Prescribing patterns among pediatric inpatients in a teaching hospital in western Nepal. Singapore Med J. 2006 Apr; 47(4):2615.

Potharaju HR, Kabra SG. Prescription audit of outpatient attendees of secondary level government hospitals in Maharashtra. Indian J Pharmacol. 2011 Apr; 43(2):1506.

Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, Almeida AF, Channakeshavamurthy A, Ballal HS, Gaccione P, Issacs R. Epidemiology and risk factors of chronic kidney disease in Indiaresults from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrology. 2013 May 28; 14(1):1.

Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, Gang S, Gupta A, Modi G, Pahari D, Pisharody R. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrology. 2012 Mar 6; 13(1):1.

Haroun MK, Jaar BG, Hoffman SC et al. Risk factors forchronic kidney disease: a prospective study of 23,534 men andwomen in Washington County, Maryland. J Am Soc Nephrol 2003; 14:29342941.

Schaeffner ES, Kurth T, Bowman TS et al. Blood pressure measures and risk of chronic kidney disease in men. Nephrol Dial Transplant 2008; 23:12461251.

Prasannakumar M, Rajput R, Seshadri K, Talwalkar P, Agarwal P, Gokulnath G, Kotak B, Raza A, Vasnawala H, Teli C. An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START-India). Indian Journal of Endocrinology and Metabolism. 2015 Jul; 19(4):520.

Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC study. Kidney Int 2003; 64:610615.

Fulton MM, Riley Allen E. Polypharmacy in the elderly: a literature review. Journal of the American Academy of Nurse Practitioners. 2005 Apr 1; 17(4):123-32.

Frazier SC. Health outcomes and polypharmacy in elderly individuals. Journal of Gerontological Nursing. 2005 Sep 1; 31(9):4-9.

Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. European Journal of Clinical Pharmacology. 1997 Oct 1; 53(1):7-11.

Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Reduction of High?Risk Polypharmacy Drug Combinations in Patients in a Managed Care Setting. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2005 Nov 1; 25(11):1636-45.

Brager R, Sloand E. The spectrum of polypharmacy. The Nurse Practitioner. 2005 Jun 1; 30(6):44-50.

Rama M, Viswanathan G, Acharya LD, Attur RP, Reddy PN, Raghavan SV. Assessment of drug-drug interactions among renal failure patients of nephrology ward in a south Indian tertiary care hospital. Indian Journal of Pharmaceutical Sciences. 2012 Jan; 74(1):63.

Bajait CS, Pimpalkhute SA, Sontakke SD, Jaiswal KM, Dawri AV. Prescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders. Indian Journal of Pharmacology. 2014 Jan; 46(1):35.

George S, Acharya LD, Prabhu AR, Mallayasamy S. Management and treatment outcome of complications of chronic kidney disease patients in a south Indian tertiary care hospital. Int J of Phar and Clin Sci 2013; 2(4):113-120.

Andrassy KM. Comments on KDIGO 2012 clinical practice guidelines for the evaluation and management of chronic kidney disease. Kidney International. 2013 Sep 1; 84(3):622-3.


DOI: https://doi.org/10.7439/ijpr.v7i4.4024


Copyright (c) 2017 International Journal of Pharmacological Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Dr. Jun Ren is a dedicated and experienced registered dietitian and nutritionist who is committed to helping people achieve their health goals through personalized nutrition plans. With a passion for promoting healthy eating habits and preventing chronic diseases, Dr. Ren has been able to assist numerous clients in improving their overall quality of life.

Leave a Comment